Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Negative headwinds on BHEL: The stock has underperformed the market by
20% over the past 12 months on the back of (1) falling domestic market share,
with Chinese firms now owning >50% share on orders placed for the 12th FYP
so far, and (2) investor concerns that BHEL might have to expand overseas to
diversify competition risk in India, which might lead to lower margins.
Most negatives priced in, more positive catalysts ahead: We believe most
negatives are now priced in for BHEL, and upcoming positive catalysts include:
(1) impending government bulk-tenders reserved for domestic producers, where
BHEL can ramp-up supercritical technology platform to lower costs and regain
market share in LT; and (2) India’s coal supply problems – private IPPs (which
mostly use Chinese equipment) might face more problems with project delays
than their public sector counterparts (which mostly use BHEL equipment).
BHEL’s fundamentals still appear stronger than China peers’: BHEL’s
stock decline over the past 12M has eroded BHEL’s valuation premium over its
Chinese counterparts from 40% a year ago to ~0% currently. This is unjustified,
in our view, because even after factoring in the expected margin decline over the
next 2-3 years, (1) BHEL still has stronger LT growth prospects in a market that
is still in an upcycle, while Chinese peers are in a market that has already
peaked, (2) Chinese peers are operating with razor-thin margins without the
ability to pass on material cost fluctuations, and (3) Chinese peers face higher
risk of increased receivable provisions as IPPs slow down repayment on
weakening profits – particularly Harbin, which has the lowest profit margin.
Overweight on BHEL, downgrade Harbin to UW: We stay OW on BHEL
(less demanding valuation at 12x FY13E P/E with better LT growth prospects),
and remain cautious on Chinese equipment makers, which are more prone to
receivable provisions, especially Harbin (downgraded from N to UW on the
back of this) which has (1) the lowest profit margin (most sensitive) and highest
exposure to coal-fired IPPs (in terms of sales), and (2) lowest exposure to
nuclear. Among the three Chinese firms, we prefer Dongfang – H (OW) thanks
to its (1) higher nuclear exposure, and (2) more upside from hydropower.
Visit http://indiaer.blogspot.com/ for complete details �� ��
Negative headwinds on BHEL: The stock has underperformed the market by
20% over the past 12 months on the back of (1) falling domestic market share,
with Chinese firms now owning >50% share on orders placed for the 12th FYP
so far, and (2) investor concerns that BHEL might have to expand overseas to
diversify competition risk in India, which might lead to lower margins.
Most negatives priced in, more positive catalysts ahead: We believe most
negatives are now priced in for BHEL, and upcoming positive catalysts include:
(1) impending government bulk-tenders reserved for domestic producers, where
BHEL can ramp-up supercritical technology platform to lower costs and regain
market share in LT; and (2) India’s coal supply problems – private IPPs (which
mostly use Chinese equipment) might face more problems with project delays
than their public sector counterparts (which mostly use BHEL equipment).
BHEL’s fundamentals still appear stronger than China peers’: BHEL’s
stock decline over the past 12M has eroded BHEL’s valuation premium over its
Chinese counterparts from 40% a year ago to ~0% currently. This is unjustified,
in our view, because even after factoring in the expected margin decline over the
next 2-3 years, (1) BHEL still has stronger LT growth prospects in a market that
is still in an upcycle, while Chinese peers are in a market that has already
peaked, (2) Chinese peers are operating with razor-thin margins without the
ability to pass on material cost fluctuations, and (3) Chinese peers face higher
risk of increased receivable provisions as IPPs slow down repayment on
weakening profits – particularly Harbin, which has the lowest profit margin.
Overweight on BHEL, downgrade Harbin to UW: We stay OW on BHEL
(less demanding valuation at 12x FY13E P/E with better LT growth prospects),
and remain cautious on Chinese equipment makers, which are more prone to
receivable provisions, especially Harbin (downgraded from N to UW on the
back of this) which has (1) the lowest profit margin (most sensitive) and highest
exposure to coal-fired IPPs (in terms of sales), and (2) lowest exposure to
nuclear. Among the three Chinese firms, we prefer Dongfang – H (OW) thanks
to its (1) higher nuclear exposure, and (2) more upside from hydropower.
No comments:
Post a Comment